Hap Trading, LLC Aprea Therapeutics, Inc. Transaction History
Hap Trading, LLC
- $1.15 Trillion
- Q4 2024
A detailed history of Hap Trading, LLC transactions in Aprea Therapeutics, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 16,100 shares of APRE stock, worth $56,833. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,100Holding current value
$56,833% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding APRE
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About Aprea Therapeutics, Inc.
- Ticker APRE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Description
- Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...